[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"node-by-slug-\u002Fen\u002Finsights\u002Fhealios-improved-patient-journey-through-digital-biomarkers-en":3,"related-content-view-3339-en":363},["Reactive",4],{"entity":5,"errors":-1},{"__typename":6,"status":7,"metatag":8,"id":202,"path":203,"hideNavigation":204,"title":205,"translations":206,"sharedHeaderRefMedia":214,"sharedTeaserTitle":13,"sharedTeaserText":238,"sharedTeaserRefMedia":240,"sharedParagraphs":242,"sharedTaxrefIndustries":339,"sharedTaxrefExpertises":346,"sharedIntroText":204,"sharedCtaLink":204,"sharedDate":350,"sharedAuthor":352},"NodeInsight",true,[9,14,18,21,25,30,34,38,42,46,50,54,58,62,66,69,73,76,79,81,84,87,91,95,99,103,107,111,115,119,123,127,131,135,139,142,145,148,151,154,157,160,163,166,170,174,177,181,185,189,193,196,200],{"tag":10,"attributes":11},"meta",{"name":12,"content":13},"title","Healios: better patient journey through digital biomarkers",{"tag":10,"attributes":15},{"name":16,"content":17},"description","Interview with Guilhem Dupont, CEO of Zühlke Ventures’ youngest Portfolio Company Healios. Healios develops digital biomarkers to both improve the journey for patients suffering from Multiple Sclerosis and to accelerate research in this space.",{"tag":10,"attributes":19},{"name":20,"content":17},"abstract",{"tag":10,"attributes":22},{"name":23,"content":24},"icbm","51.525772, -0.082716",{"tag":26,"attributes":27},"link",{"rel":28,"href":29},"shortlink","https:\u002F\u002Fcms.zuehlke.com\u002Fapi\u002Fgraphql",{"tag":26,"attributes":31},{"rel":32,"href":33},"canonical","https:\u002F\u002Fcms.zuehlke.com\u002Fen\u002Finsights\u002Fhealios-improved-patient-journey-through-digital-biomarkers",{"tag":10,"attributes":35},{"name":36,"content":37},"robots","index, follow",{"tag":26,"attributes":39},{"rel":40,"href":41},"image_src","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Fmax_1300x1300\u002Fpublic\u002Fimages\u002Fdigital_patient.png?itok=kmX1Luaf,https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":43},{"name":44,"content":45},"referrer","unsafe-url",{"tag":10,"attributes":47},{"name":48,"content":49},"rights","Copyright ©2026 | Zühlke Engineering AG | All rights reserved.",{"tag":10,"attributes":51},{"property":52,"content":53},"og:site_name","Zühlke Engineering AG",{"tag":10,"attributes":55},{"property":56,"content":57},"og:type","website",{"tag":10,"attributes":59},{"property":60,"content":61},"og:url","https:\u002F\u002Fwww.zuehlke.com\u002Fen\u002Finsights\u002Fhealios-improved-patient-journey-through-digital-biomarkers",{"tag":10,"attributes":63},{"property":64,"content":65},"og:title","Healios: better patient journey through digital biomarkers – Zühlke",{"tag":10,"attributes":67},{"property":68,"content":17},"og:description",{"tag":10,"attributes":70},{"property":71,"content":72},"og:image","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Fmax_1300x1300\u002Fpublic\u002Fimages\u002Fdigital_patient.png?itok=kmX1Luaf",{"tag":10,"attributes":74},{"property":71,"content":75},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":77},{"property":78,"content":72},"og:image:url",{"tag":10,"attributes":80},{"property":78,"content":75},{"tag":10,"attributes":82},{"property":83,"content":72},"og:image:secure_url",{"tag":10,"attributes":85},{"property":83,"content":86},"https:\u002F\u002Fwww.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":88},{"property":89,"content":90},"og:updated_time","2025-12-29",{"tag":10,"attributes":92},{"property":93,"content":94},"og:image:alt","image",{"tag":10,"attributes":96},{"property":97,"content":98},"place:location:latitude","46.947944",{"tag":10,"attributes":100},{"property":101,"content":102},"place:location:longitude","7.438014",{"tag":10,"attributes":104},{"property":105,"content":106},"og:street_address","80 Great Eastern Street",{"tag":10,"attributes":108},{"property":109,"content":110},"og:locality","London",{"tag":10,"attributes":112},{"property":113,"content":114},"og:region","England",{"tag":10,"attributes":116},{"property":117,"content":118},"og:postal_code","EC2A 3JL",{"tag":10,"attributes":120},{"property":121,"content":122},"og:country_name","United Kingdom",{"tag":10,"attributes":124},{"property":125,"content":126},"og:email","london@zuhlke.com",{"tag":10,"attributes":128},{"property":129,"content":130},"og:phone_number","+44 20 7113 5000",{"tag":10,"attributes":132},{"property":133,"content":134},"og:locale","en_CH",{"tag":10,"attributes":136},{"property":137,"content":138},"og:locale:alternate","de_CH",{"tag":10,"attributes":140},{"property":137,"content":141},"de_DE",{"tag":10,"attributes":143},{"property":137,"content":144},"en_DE",{"tag":10,"attributes":146},{"property":137,"content":147},"en_AT",{"tag":10,"attributes":149},{"property":137,"content":150},"de_AT",{"tag":10,"attributes":152},{"property":137,"content":153},"en_HK",{"tag":10,"attributes":155},{"property":137,"content":156},"en_SR",{"tag":10,"attributes":158},{"property":137,"content":159},"en_BG",{"tag":10,"attributes":161},{"property":137,"content":162},"en_SG",{"tag":10,"attributes":164},{"property":137,"content":165},"en_GB",{"tag":10,"attributes":167},{"property":168,"content":169},"article:publisher","https:\u002F\u002Fwww.facebook.com\u002Fzuehlke.group",{"tag":10,"attributes":171},{"property":172,"content":173},"article:published_time","2021-03-31",{"tag":10,"attributes":175},{"property":176,"content":90},"article:modified_time",{"tag":10,"attributes":178},{"name":179,"content":180},"twitter:card","summary_large_image",{"tag":10,"attributes":182},{"name":183,"content":184},"twitter:site","@zuehlke_group",{"tag":10,"attributes":186},{"name":187,"content":188},"twitter:site:id","247189965",{"tag":10,"attributes":190},{"name":191,"content":192},"twitter:image","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Fmax_1300x1300\u002Fpublic\u002Fimages\u002Fdigital_patient.png?itok=kmX1Luaf,https:\u002F\u002Fwww.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":194},{"name":195,"content":94},"twitter:image:alt",{"tag":10,"attributes":197},{"name":198,"content":199},"google-site-verification","VEzolc1Vxy1KyRIlIqUSmVS7fqP_3_ZeBqPRby4g2mE",{"tag":201},"script","3339","\u002Fen\u002Finsights\u002Fhealios-improved-patient-journey-through-digital-biomarkers",null,"Healios: improved patient journey through digital biomarkers",[207,210],{"path":203,"langcode":208},{"id":209},"en",{"path":211,"langcode":212},"\u002Fde\u002Finsights\u002Fhealios-das-leben-der-patienten-erleichtern-durch-digitale-biomarker",{"id":213},"de",{"id":215,"sharedMediaLegend":204,"mediaImage":216,"name":237},"2542",{"url":217,"width":218,"height":219,"alt":220,"title":204,"size":221,"mime":222,"variations":204,"headerMinimalVariations":223},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fdigital_patient.png",702,576,"healthcare professional analyzing data with tablet and PC",530272,"image\u002Fpng",[224,228,229,233,236],{"name":225,"url":226,"width":218,"height":227},"FOCAL_POINT32_SMALL","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Fdigital_patient.png.webp?itok=oyrzleIO",468,{"name":225,"url":226,"width":218,"height":227},{"name":230,"url":231,"width":218,"height":232},"FOCAL_POINT169_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_16_9_medium\u002Fpublic\u002Fimages\u002Fdigital_patient.png.webp?itok=NFzcjH4F",395,{"name":234,"url":235,"width":218,"height":232},"FOCAL_POINT169_LARGE","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_16_9_large\u002Fpublic\u002Fimages\u002Fdigital_patient.png.webp?itok=mq3UYeeH",{"name":234,"url":235,"width":218,"height":232},"digital_patient.png",{"processed":239},"\u003Cp>Interview with Guilhem Dupont, CEO of Zühlke Ventures’ youngest Portfolio Company Healios. Healios develops digital biomarkers to both improve the journey for patients suffering from Multiple Sclerosis and to accelerate research in this space.\u003C\u002Fp>",{"id":215,"sharedMediaLegend":204,"mediaImage":241,"name":237},{"url":217,"width":218,"height":219,"alt":220,"title":204,"size":221,"mime":222,"variations":204},[243,250,255,260,265,291,296,301,306],{"__typename":244,"id":245,"ctaLink":204,"pgSharedText":246,"pgSharedTitle":204,"pgSharedCtaLink":204},"ParagraphPgText","23422",{"value":247,"processed":248,"format":249},"\u003Cul>\r\n\t\u003Cli>\r\n\t\u003Cp class=\"text-lead\">Healios develops digital biomarkers to improve the journey for\u003Cbr \u002F>\r\n\tpatients suffering from Multiple Sclerosis\u003C\u002Fp>\r\n\t\u003C\u002Fli>\r\n\t\u003Cli>\r\n\t\u003Cp class=\"text-lead\">This also helps to accelerate research in this space\u003C\u002Fp>\r\n\t\u003C\u002Fli>\r\n\t\u003Cli>\r\n\t\u003Cp class=\"text-lead\">Healthcare offers tremendous opportunities in the era of digital transformation\u003C\u002Fp>\r\n\t\u003C\u002Fli>\r\n\u003C\u002Ful>\r\n","\u003Cul>\n\t\u003Cli>\n\t\u003Cp class=\"text-lead\">Healios develops digital biomarkers to improve the journey for\u003Cbr>\n\tpatients suffering from Multiple Sclerosis\u003C\u002Fp>\n\t\u003C\u002Fli>\n\t\u003Cli>\n\t\u003Cp class=\"text-lead\">This also helps to accelerate research in this space\u003C\u002Fp>\n\t\u003C\u002Fli>\n\t\u003Cli>\n\t\u003Cp class=\"text-lead\">Healthcare offers tremendous opportunities in the era of digital transformation\u003C\u002Fp>\n\t\u003C\u002Fli>\n\u003C\u002Ful>","full_html",{"__typename":244,"id":251,"ctaLink":204,"pgSharedText":252,"pgSharedTitle":204,"pgSharedCtaLink":204},"10414",{"value":253,"processed":254,"format":204},"Healios develops digital biomarkers to both improve the journey for patients suffering from Multiple Sclerosis and to accelerate research in this space. Interview with Guilhem Dupont, CEO of Zühlke Ventures’ youngest Portfolio Company Healios. ","\u003Cp>Healios develops digital biomarkers to both improve the journey for patients suffering from Multiple Sclerosis and to accelerate research in this space. Interview with Guilhem Dupont, CEO of Zühlke Ventures’ youngest Portfolio Company Healios. \u003C\u002Fp>\n",{"__typename":244,"id":256,"ctaLink":204,"pgSharedText":257,"pgSharedTitle":204,"pgSharedCtaLink":204},"5659",{"value":258,"processed":259,"format":249},"\u003Cp>\u003Cem>\u003Cstrong>Guilhem, why did you leave an attractive corporate career to found Healios?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr \u002F>\r\n\u003Cbr \u002F>\r\nHealthcare offers tremendous opportunities in this age of digital transformation. There is an unmet need for stronger real-world data to measure the effectiveness of treatments and the need for more accurate diagnostic tools that allow personalisation of treatments. That's where Healios comes in: we use sensor data of wearables and smartphones to quantify the progression of neurological diseases, for example Multiple Sclerosis (MS).\u003Cspan style=\"font-size:11pt\">\u003Cspan style=\"vertical-align:middle\">\u003Cspan style=\"font-family:Calibri,sans-serif\">\u003Cspan lang=\"EN-GB\" style=\"font-size:12.0pt\">\u003Cspan style=\"font-family:"Arial",sans-serif\">\u003Cspan style=\"color:black\"> \u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fp>\r\n","\u003Cp>\u003Cem>\u003Cstrong>Guilhem, why did you leave an attractive corporate career to found Healios?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr>\n\u003Cbr>\nHealthcare offers tremendous opportunities in this age of digital transformation. There is an unmet need for stronger real-world data to measure the effectiveness of treatments and the need for more accurate diagnostic tools that allow personalisation of treatments. That's where Healios comes in: we use sensor data of wearables and smartphones to quantify the progression of neurological diseases, for example Multiple Sclerosis (MS).\u003Cspan>\u003Cspan>\u003Cspan>\u003Cspan lang=\"EN-GB\">\u003Cspan>\u003Cspan> \u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fspan>\u003C\u002Fp>",{"__typename":244,"id":261,"ctaLink":204,"pgSharedText":262,"pgSharedTitle":204,"pgSharedCtaLink":204},"5668",{"value":263,"processed":264,"format":249},"\u003Cp>\u003Cem>\u003Cstrong>Why is this valuable?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr \u002F>\r\n\u003Cbr \u002F>\r\nOur solution enables specialist doctors to determine disease progression earlier and more precisely than present methods and thus adapt treatment to reduce disease progression and accumulation of handicaps. With benefits for patients, physicians and health insurances. With the same solution we are also able to empower clinical research, an area where we see exponential adoption of digital solutions in the wake of Covid-19.\u003C\u002Fp>\r\n","\u003Cp>\u003Cem>\u003Cstrong>Why is this valuable?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr>\n\u003Cbr>\nOur solution enables specialist doctors to determine disease progression earlier and more precisely than present methods and thus adapt treatment to reduce disease progression and accumulation of handicaps. With benefits for patients, physicians and health insurances. With the same solution we are also able to empower clinical research, an area where we see exponential adoption of digital solutions in the wake of Covid-19.\u003C\u002Fp>",{"__typename":266,"id":267,"caption":204,"imageRight":204,"pgSharedTitle":204,"pgSharedCtaLink":204,"textMedia":268,"pgSharedText":288},"ParagraphPgTextMedia","5669",{"id":269,"sharedMediaLegend":204,"mediaImage":270,"name":287},"2543",{"url":271,"width":272,"height":273,"alt":274,"title":204,"size":275,"mime":276,"variations":204,"textMediaVariations":277},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fportrait_guilhem-dupont.jpg",388,342,"portrait of Guilhem Dupont, CEO Healios",19264,"image\u002Fjpeg",[278,281,282,283,286],{"name":279,"url":280,"width":272,"height":273},"FIXED_WIDTH_SMALL","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffixed_width_small\u002Fpublic\u002Fimages\u002Fportrait_guilhem-dupont.jpg.webp?itok=Y0F9oqU4",{"name":279,"url":280,"width":272,"height":273},{"name":279,"url":280,"width":272,"height":273},{"name":284,"url":285,"width":272,"height":273},"FIXED_WIDTH_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffixed_width_medium\u002Fpublic\u002Fimages\u002Fportrait_guilhem-dupont.jpg.webp?itok=s5k5JwL3",{"name":284,"url":285,"width":272,"height":273},"portrait_guilhem-dupont.jpg",{"value":289,"processed":290,"format":249},"\u003Cp>\u003Cstrong>Guilhem Dupont\u003C\u002Fstrong>\u003Cbr \u002F>\r\n\u003Cbr \u002F>\r\n\u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fguilhem-dupont-8271591\u002F\">Guilhem Dupont\u003C\u002Fa> is passionate about empowering patients and caregivers affected by a chronic condition. Guilhem worked for 12 years in global leadership roles at Johnson & Johnson and Roche.\u003C\u002Fp>\r\n","\u003Cp>\u003Cstrong>Guilhem Dupont\u003C\u002Fstrong>\u003Cbr>\n\u003Cbr>\n\u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fguilhem-dupont-8271591\u002F\">Guilhem Dupont\u003C\u002Fa> is passionate about empowering patients and caregivers affected by a chronic condition. Guilhem worked for 12 years in global leadership roles at Johnson & Johnson and Roche.\u003C\u002Fp>",{"__typename":244,"id":292,"ctaLink":204,"pgSharedText":293,"pgSharedTitle":204,"pgSharedCtaLink":204},"5670",{"value":294,"processed":295,"format":249},"\u003Cp>\u003Cem>\u003Cstrong>Which partners support you on your way?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr \u002F>\r\n\u003Cbr \u002F>\r\nWe are very happy to be part of a world-leading group of well-aligned partners across the value chain. Internationally renowned \u003Ca href=\"https:\u002F\u002Fdkf.unibas.ch\u002Fen\u002Frc2nb\u002F\" target=\"_blank\">RC2NB\u003C\u002Fa> (Research Center for Clinical Neuroimmunology and Neuroscience Basel) lead by Prof. Ludwig Kappos, is leading the way for MS therapeutics and comprehensive disease assessment. The Center is also strongly engaged in the research of digital biomarkers for MS and has signed cooperation agreements with both \u003Ca href=\"https:\u002F\u002Fwww.roche.com\u002F\" target=\"_blank\">Roche\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fwww.novartis.com\u002F\" target=\"_blank\">Novartis\u003C\u002Fa> for further accelerating research and implementation. Zühlke Ventures, besides having been a corner investor in our seed round, provides valuable support preparing us for scale-up.\u003C\u002Fp>\r\n","\u003Cp>\u003Cem>\u003Cstrong>Which partners support you on your way?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr>\n\u003Cbr>\nWe are very happy to be part of a world-leading group of well-aligned partners across the value chain. Internationally renowned \u003Ca href=\"https:\u002F\u002Fdkf.unibas.ch\u002Fen\u002Frc2nb\u002F\" target=\"_blank\">RC2NB\u003C\u002Fa> (Research Center for Clinical Neuroimmunology and Neuroscience Basel) lead by Prof. Ludwig Kappos, is leading the way for MS therapeutics and comprehensive disease assessment. The Center is also strongly engaged in the research of digital biomarkers for MS and has signed cooperation agreements with both \u003Ca href=\"https:\u002F\u002Fwww.roche.com\u002F\" target=\"_blank\">Roche\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fwww.novartis.com\u002F\" target=\"_blank\">Novartis\u003C\u002Fa> for further accelerating research and implementation. Zühlke Ventures, besides having been a corner investor in our seed round, provides valuable support preparing us for scale-up.\u003C\u002Fp>",{"__typename":244,"id":297,"ctaLink":204,"pgSharedText":298,"pgSharedTitle":204,"pgSharedCtaLink":204},"5671",{"value":299,"processed":300,"format":249},"\u003Cp>\u003Cem>\u003Cstrong>Where do you see your biggest challenges?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr \u002F>\r\n\u003Cbr \u002F>\r\nWe have successfully developed other digital health products in the past and built a well-structured organisation. The main challenge is to manage fast growth to meet demand.\u003C\u002Fp>\r\n","\u003Cp>\u003Cem>\u003Cstrong>Where do you see your biggest challenges?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr>\n\u003Cbr>\nWe have successfully developed other digital health products in the past and built a well-structured organisation. The main challenge is to manage fast growth to meet demand.\u003C\u002Fp>",{"__typename":244,"id":302,"ctaLink":204,"pgSharedText":303,"pgSharedTitle":204,"pgSharedCtaLink":204},"5672",{"value":304,"processed":305,"format":249},"\u003Cp>\u003Cem>\u003Cstrong>Where do you see the next milestones for Healios?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr \u002F>\r\n\u003Cbr \u002F>\r\nWe are confident to be able to attract more partners to the ecosystem and are looking forward to really improve the lives of individuals suffering from neurological diseases in the long term.\u003C\u002Fp>\r\n","\u003Cp>\u003Cem>\u003Cstrong>Where do you see the next milestones for Healios?\u003C\u002Fstrong>\u003C\u002Fem>\u003Cbr>\n\u003Cbr>\nWe are confident to be able to attract more partners to the ecosystem and are looking forward to really improve the lives of individuals suffering from neurological diseases in the long term.\u003C\u002Fp>",{"__typename":307,"id":308,"title":204,"pgContactRefContacts":309,"showEmail":204,"showPhone":204},"ParagraphPgContact","5673",[310],{"contactName":311,"contactProfession":312,"contactDesc":313,"contactLinkedinUrl":315,"sharedEmail":318,"sharedPhone":319,"sharedRefMedia":320},"Patrick Griss","CEO Ventures & Partner",{"value":314},"",{"title":314,"url":316,"internal":317},"http:\u002F\u002Flinkedin.com\u002Fin\u002Fpatrick-griss-5b44a07",false,"patrick.griss@zuehlke.com","+41 43 216 6609",{"id":321,"sharedMediaLegend":204,"mediaImage":322,"name":338},"172061",{"url":323,"width":324,"height":324,"alt":325,"title":204,"size":326,"mime":276,"variations":204,"personVariations":327},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002FPatrick-Griss-1000x1000px.jpg",1000,"Patrick Griss, Zühlke",244558,[328,332,333,336,337],{"name":329,"url":330,"width":331,"height":331},"FOCAL_POINT11_SMALL","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_1_1_small\u002Fpublic\u002Fimages\u002FPatrick-Griss-1000x1000px.jpg.webp?itok=7-4ZdwfA",800,{"name":329,"url":330,"width":331,"height":331},{"name":334,"url":335,"width":324,"height":324},"FOCAL_POINT11_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_1_1_medium\u002Fpublic\u002Fimages\u002FPatrick-Griss-1000x1000px.jpg.webp?itok=-RC0Pygr",{"name":334,"url":335,"width":324,"height":324},{"name":334,"url":335,"width":324,"height":324},"Patrick-Griss-1000x1000px.jpg",[340,343],{"id":341,"name":342},"13","MedTech",{"id":344,"name":345},"12","Pharma",[347],{"id":348,"name":349},"21","Software engineering",{"timestamp":351},1617192000,[353],{"status":7,"contactName":311,"contactProfession":312,"contactLinkedinUrl":354,"sharedEmail":318,"sharedRefMedia":355},{"title":314,"url":316,"internal":317},{"id":321,"sharedMediaLegend":204,"mediaImage":356,"name":338},{"url":323,"width":324,"height":324,"alt":325,"title":204,"size":326,"mime":276,"variations":204,"authorVariations":357},[358,359,360,361,362],{"name":329,"url":330,"width":331,"height":331},{"name":329,"url":330,"width":331,"height":331},{"name":329,"url":330,"width":331,"height":331},{"name":329,"url":330,"width":331,"height":331},{"name":329,"url":330,"width":331,"height":331},[364,397,441,467],{"id":365,"path":366,"sharedTeaserTitle":367,"sharedTeaserRefMedia":368,"sharedTaxrefIndustries":388,"sharedTaxrefExpertises":392},"7452","\u002Fen\u002Finsights\u002Flow-code\u002Fbimodal-IT-low-code","Keep the core clean with bimodal IT and low code",{"id":369,"sharedMediaLegend":204,"mediaImage":370,"name":387},"152319",{"url":371,"width":372,"height":373,"alt":374,"title":204,"size":375,"mime":276,"variations":204,"relatedContentVariations":376},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fbimodal-it-lowcode.jpg",1280,960,"Conceptual still life with teamwork and achievement",20793,[377,380,381,385,386],{"name":225,"url":378,"width":331,"height":379},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Fbimodal-it-lowcode.jpg.webp?itok=I2kpLXHE",533,{"name":225,"url":378,"width":331,"height":379},{"name":382,"url":383,"width":384,"height":331},"FOCAL_POINT32_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002Fbimodal-it-lowcode.jpg.webp?itok=m_5emfQH",1200,{"name":382,"url":383,"width":384,"height":331},{"name":382,"url":383,"width":384,"height":331},"bimodal-it-lowcode.jpg",[389],{"id":390,"name":391},"10","Industrial sector",[393,394],{"id":348,"name":349},{"id":395,"name":396},"897","Low code",{"id":398,"path":399,"sharedTeaserTitle":400,"sharedTeaserRefMedia":401,"sharedTaxrefIndustries":419,"sharedTaxrefExpertises":421},"26290","\u002Fen\u002Finsights\u002Fsubscription-business-the-growth-opportunity-for-equipment-machinery-manufacturers","Subscription-based business models as growth opportunity",{"id":402,"sharedMediaLegend":204,"mediaImage":403,"name":418},"171137",{"url":404,"width":405,"height":406,"alt":407,"title":204,"size":408,"mime":276,"variations":204,"relatedContentVariations":409},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fsubscription-business-manufacturing_1.jpg",768,1152,"\"\"",151231,[410,413,414,416,417],{"name":225,"url":411,"width":405,"height":412},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Fsubscription-business-manufacturing_1.jpg.webp?itok=xetwYpQc",512,{"name":225,"url":411,"width":405,"height":412},{"name":382,"url":415,"width":405,"height":412},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002Fsubscription-business-manufacturing_1.jpg.webp?itok=2vKskNW8",{"name":382,"url":415,"width":405,"height":412},{"name":382,"url":415,"width":405,"height":412},"subscription-business-manufacturing.jpg",[420],{"id":390,"name":391},[422,425,428,431,434,437,438],{"id":423,"name":424},"19","Digital strategy",{"id":426,"name":427},"887","Business transformation",{"id":429,"name":430},"892","Ecosystems",{"id":432,"name":433},"20","Hardware engineering",{"id":435,"name":436},"885","IoT & connected devices",{"id":348,"name":349},{"id":439,"name":440},"884","Mobile applications",{"id":442,"path":443,"sharedTeaserTitle":444,"sharedTeaserRefMedia":445,"sharedTaxrefIndustries":462,"sharedTaxrefExpertises":465},"5893","\u002Fen\u002Finsights\u002Fcompliant-framework-for-cloud-based-innovation-in-pharma-medtech","Compliant Framework for Cloud-Based Innovation in Pharma & MedTech ",{"id":446,"sharedMediaLegend":204,"mediaImage":447,"name":461},"4914",{"url":448,"width":384,"height":449,"alt":450,"title":204,"size":451,"mime":276,"variations":204,"relatedContentVariations":452},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fheader_landing_mc_0.jpg",600,"How cloud-based medtech & pharma innovation and regulation can work together for good.",568484,[453,455,456,459,460],{"name":225,"url":454,"width":331,"height":379},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Fheader_landing_mc_0.jpg.webp?itok=MbAgfkTD",{"name":225,"url":454,"width":331,"height":379},{"name":382,"url":457,"width":458,"height":449},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002Fheader_landing_mc_0.jpg.webp?itok=j24FJyem",900,{"name":382,"url":457,"width":458,"height":449},{"name":382,"url":457,"width":458,"height":449},"header_landing_mc.jpg",[463,464],{"id":341,"name":342},{"id":344,"name":345},[466],{"id":348,"name":349},{"id":468,"path":469,"sharedTeaserTitle":470,"sharedTeaserRefMedia":471,"sharedTaxrefIndustries":489,"sharedTaxrefExpertises":493},"5916","\u002Fen\u002Finsights\u002Fwhen-should-you-consider-using-a-progressive-web-app","When should you consider using a progressive web app?",{"id":472,"sharedMediaLegend":204,"mediaImage":473,"name":488},"4949",{"url":474,"width":475,"height":476,"alt":477,"title":204,"size":478,"mime":276,"variations":204,"relatedContentVariations":479},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fprogressive-web-app.jpg",1133,850,"hands working on a laptop with sheets about mobile apps beside",195721,[480,482,483,486,487],{"name":225,"url":481,"width":331,"height":379},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Fprogressive-web-app.jpg.webp?itok=aAgfElF-",{"name":225,"url":481,"width":331,"height":379},{"name":382,"url":484,"width":475,"height":485},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002Fprogressive-web-app.jpg.webp?itok=c3EDiuVJ",756,{"name":382,"url":484,"width":475,"height":485},{"name":382,"url":484,"width":475,"height":485},"progressive-web-app.jpg",[490],{"id":491,"name":492},"855","All industries",[494],{"id":348,"name":349}]